News
07-27-2023, 05:31 AM
TNBC is a particularly aggressive subtype of breast cancer, characterized by the absence of three key receptors: estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2).
More... (https://www.news-medical.net/news/20230726/Core-promoter-variation-may-drive-development-of-triple-negative-breast-cancer.aspx)
More... (https://www.news-medical.net/news/20230726/Core-promoter-variation-may-drive-development-of-triple-negative-breast-cancer.aspx)